Model showing how Dysport can make you feel a beautiful boost

Enjoy the beauty 

of self-expression

Dysport is a convenient way to feel a beautiful boost, but not a total transformation. With 95% of users* satisfied with only 2 treatments per year,1† and 97% of users* agreeing that the treatment looked natural.1† Dysport delivers noticeable results in as little as 24 hours after treatment, with results typically appearing within 2-3 days.2-4‡
  • Users=clinical trial subjects.
  • Subject-reported at 12 months (N=120) after two treatments six months apart in a phase IV, multicenter, prospective study.
  • Based on subject self-assessment. The onset of response at day 1 was 15% (16/105) in GL-1 and 33% (65/200) in GL-3. In the DREAM study, the onset of response at day 1 was 33% (66/200). The median time to onset of response was 3 days in GL-1 (55/105; 52%) and GL-2 (36/71; 51%), and 2 days in GL-3 (110/200; 55%).
  • Actual patient. Individual results may vary.
Actual Dysport patient smiling after their treatment

Enhance the bold, beautiful, and brilliant you

With more than 2.3 million people in the US1,5-7 and 100 million people worldwide choosing Dysport,8 people like what they see and how they feel after treatment.1

    Actual patient. Individual results may vary.

Confidence-building satisfaction

  • 98%
    of users* would get another
    Dysport treatment.1
  • 95%
    of users* felt confident,
    attractive, and happy after
    their treatment.1†‡
  • 100%
    of 21- to 30-year-old
    users* were satisfied after 2
    treatments, 6 months apart.9§
98%
of users* would get another
Dysport treatment.1
95%
of users* felt confident,
attractive, and happy after
their treatment.1†‡
100%
of 21- to 30-year-old
users* were satisfied after 2
treatments, 6 months apart.9§

    *Users=clinical trial subjects.
    †Subject-reported at 12 months (N=120) after two treatments
    
six months apart in a phase IV, multicenter, prospective study.
    ‡3 out of 10 FACE-Q questions about psychological function are shown.
    §Subject-reported at 12 months (N=16/16) after two treatments
    
six months apart in a phase IV, multicenter, prospective study.

Explore Before & Afters

Explore unretouched images of real people

who chose Dysport for a natural, not frozen, look.
Dysport patient Aila before treatment
Dysport patient Aila after treatment
Aila was treated with 50 units of Dysport in the frown lines.

32 days after initial treatment. Actual patient. Individual results may vary.
View gallery
Actual Dysport patients smiling and showing treatment results

Fast-acting, long-lasting treatment9-12*†

Dysport® works by smoothing out wrinkles, which are caused by repeated movements and muscle contractions.13 One injection into each of the 5 points between and above the eyebrows temporarily prevents muscle contractions that cause frown lines.14 In other words: natural-looking results10 that look and feel like you.

Just one 10-20–minute treatment may help improve the look of the frown lines between your eyebrows for up to 5 months.3-5† Results of repeat treatments may be comparable to your first treatment.10,15,16 Another plus? There’s minimal downtime after your treatment, which means you can get back to your day faster.

  • Based on subject self-assessment at day 2 or 3. The median time to onset of response was 3 days in GL-1 (55/105; 52%) and GL-2 (36/71; 51%), and 2 days in GL-3 (110/200; 55%).
  • GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline utilizing data from two double-blinded, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.
    Actual patients. Individual results may vary.

Actual vial of Dysport product

What you can expect

Discuss with your doctor your treatment expectations and any health conditions or allergies you may have that could interfere with your treatment.

Actual patient showing positions for Dysport treatment injections

Your treatment

Effective treatment requires 1 injection into each of 5 points between and above the eyebrows. Although office visit times vary, the procedure generally takes 10 to 20 minutes. Your healthcare professional will determine the exact placement of each injection for the best results.

Actual patient. Individual results may vary.
Actual patient showing results after Dysport treatment

Results following treatment

There should be little to no downtime after your treatment. Dysport delivers noticeable results in as little as 24 hours after treatment, and typically within 2-3 days, with results that may last up to 5 months.2-5*† Results of repeat treatments may be comparable to your first treatment.10,15,16
See more Dysport results
  •   Although the experience described is typical, the general routine at your doctor’s office may differ. Individual results may vary.
  • Based on subject self-assessment. The onset of response at day 1 was 15% (16 patients out of 105) in GL-1 and 33% (65 patients out of 200) in GL-3. In the DREAM study, the onset of response at day 1 was 33% (66 patients out of 200). The median time to onset of response was 3 days in GL-1 (55 patients out of 105; 52%) and GL-2 (36 patients out of 71; 51%), and 2 days in GL-3 (110 patients out of 200; 55%).
  • GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline, utilizing data from 2 double-blind, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.
    Actual patient. Individual results may vary.
  •   Although the experience described is typical, the general routine at your doctor’s office may differ. Individual results may vary.
  • Based on subject self-assessment. The onset of response at day 1 was 15% (16 patients out of 105) in GL-1 and 33% (65 patients out of 200) in GL-3. In the DREAM study, the onset of response at day 1 was 33% (66 patients out of 200). The median time to onset of response was 3 days in GL-1 (55 patients out of 105; 52%) and GL-2 (36 patients out of 71; 51%), and 2 days in GL-3 (110 patients out of 200; 55%).
  • GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline, utilizing data from 2 double-blind, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.
    Actual patient. Individual results may vary.

Find a specialist

Our network of specialists can answer questions you might have about Dysport or any Galderma treatment, so you can stay uniquely you.

Find an aesthetic injector near you to make an appointment.

map
Map data ©2023 Google.

Join ASPIRE Galderma Rewards to start earning points with qualifying treatments.

Every 100 points = $10 of valuable savings on more of the treatments along your aesthetic journey.

Sign up today and receive a $20 Welcome Reward* for your next treatment.

Start earning
*Offer terms and conditions apply.

@DysportUSA

Actual patients. Individual results may vary.

Follow us on Instagram
References
  1. Data on file. 43USD1802 Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2020.
  2. Data on file. GL-Y-97-52120-085 (GL-2) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
  3. Data on file. GL-Y-97-52120-719 (GL-1) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
  4. Data on file. GL-Y-97-52120-718 (GL-3) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.
  5. Data on file. MA-41196 Clinical Study Report. Galderma Laboratories, L.P., June 2019.
  6. Data on file. ASPIRE database. Fort Worth, TX: Galderma Laboratories, L.P. Accessed on 9/29/22.
  7. Data on file. 43USD1801 Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2020.
  8. Data on file. MA-52573 More Than 100 Million Dysport Azzalure Treatments.
  9. Data on file. MA-35497. Post Hoc Analysis. Fort Worth, TX: Galderma Laboratories, L.P., 2017.
  10. Rubin MG, et al. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol. 2009;8(5):439-444.
  11. Monheit GD, et al. Efficacy, safety, and subject satisfaction after abobotulinumtoxinA treatment for moderate to severe glabellar lines. Dermatol Surg. 2020;46(1):61-69.
  12. Brandt F, et al. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Dermatol Surg. 2009;35(12):1893-1901.
  13. Molina B, et al. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. J Eur Acad Dermatol Venereol. 2015;29(7):1382-1388.
  14. Dysport Prescribing Information. Galderma Laboratories, L.P. Dallas, TX. 2023.
  15. Moy R, et al. Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines. Arch Facial Plast Surg. 2009;11(2):77-83.
  16. Cohen JL, et al. An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. Aesthet Surg J. 2009;29(6 Suppl):S43-S49.
Please see full Important Safety Information
for Dysport, for frown lines between the brows,including Distant Spread of Toxin Effect Boxed Warning at bottom of page.
Please see full Important Safety Information

for Dysport, for frown lines between the brows, including Distant Spread of Toxin Effect Boxed Warning at bottom of page.

Important Safety Information

Dysport® (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.

Important Safety Information

What is the most important information you should know about Dysport? Spread of Toxin Effects: In some cases, the effects of Dysport and all botulinum toxin products may affect areas of the body away from the injection site. Symptoms can happen hours to weeks after injection and may include swallowing and breathing problems, loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, or loss of bladder control. Swallowing and breathing problems can be life threatening and there have been reports of death. You are at the highest risk if these problems are pre-existing before injection.

These effects could make it unsafe for you to drive a car, operate machinery, or do other dangerous activities.

Do not have Dysport treatment if you: are allergic to Dysport or any of its ingredients (see the end of the Medication Guide for a list of ingredients), are allergic to cow's milk protein, had an allergic reaction to any other botulinum toxin product, such as Myobloc®, Botox®, or Xeomin®, have a skin infection at the planned injection site, under 18 years of age, or are pregnant or breastfeeding.

The dose of Dysport is not the same as the dose of any other botulinum toxin product and cannot be compared to the dose of any other product you may have used.

Tell your doctor about any swallowing or breathing difficulties and all your muscle or nerve conditions such as amyotrophic lateral sclerosis [ALS or Lou Gehrig's disease], myasthenia gravis, or Lambert-Eaton syndrome, which may increase the risk of serious side effects including difficulty swallowing and difficulty breathing. Serious allergic reactions have occurred with the use of Dysport. Dry eye has also been reported.

Tell your doctor about all of your medical conditions, including if you have surgical changes to your face, very weak muscles in the treatment area, any abnormal facial change, injection site inflammation, droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, wrinkles that can't be smoothed by spreading them apart, or if you are pregnant or breastfeeding or planning to become pregnant or breastfeed.

Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins and herbal and other natural products. Using Dysport with certain other medicines may cause serious side effects. Do not start any new medicines while taking Dysport without talking to your doctor first.

Especially tell your doctor if you: have received any other botulinum toxin product, such as Myobloc® (rimabotulinumtoxinB), Botox® (onabotulinumtoxinA), or Xeomin® (incobotulinumtoxinA), in the last four months or any in the past (be sure your doctor knows exactly which product you received), have recently received an antibiotic by injection, take muscle relaxants, take an allergy or cold medicine, or take a sleep medicine.

Common Side Effects

The most common side effects are nose and throat irritation, headache, injection site pain, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea.

Ask your doctor if Dysport is right for you.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Dysport Full Prescribing Information including Medication Guide.

US-DYS-2300210